Shares of Cell MedX Corp (OTCMKTS:CMXC) were up 4.4% during trading on Tuesday . The company traded as high as $0.30 and last traded at $0.30, approximately 43,900 shares traded hands during mid-day trading. An increase of 55% from the average daily volume of 28,325 shares. The stock had previously closed at $0.29.
The business’s 50-day simple moving average is $0.30 and its two-hundred day simple moving average is $0.44.
About Cell MedX (OTCMKTS:CMXC)
Cell MedX Corp., a development stage company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, and high blood pressure. It also develops and manufactures eBalance technology that is in the research and development stage to manage diabetes mellitus and its complications.
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.